Results 121 to 130 of about 7,193 (177)

Screening for Fabry Disease Among Dialysis Patients: A Multicenter Cross-Sectional Study in Türkiye with Cascade Screening of Identified Cases. [PDF]

Medicina (Kaunas)
Atılgan KG, Aylı BI, Aylı MD.
europepmc   +1 more source

Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. [PDF]

Dis Model Mech
Elsaid H, Furriol J, Eikrem Ø, Tøndel C, Svarstad E.   +4 more
europepmc   +1 more source

Expert Opinion on the Conceptual, Clinical, and Therapeutic Aspects of Fabry Nephropathy: A Nephrologists' Perspective.

Kidney Blood Press Res
Eren N, Turkmen K, Turgut F, Tokgoz B, Inci A, Seyahi N.   +5 more
europepmc   +1 more source

Case Report: Concurrent Fabry disease, IgA nephropathy and undifferentiated connective tissue disease in a female with normal enzyme activity. [PDF]

Front Immunol
Cui A, Ma S, Sun T, Chang M, Lu S, Fu S, Xu H.   +6 more
europepmc   +1 more source

Key considerations for measuring α-galactosidase A activity after long-term migalastat therapy-Avoiding in vitro inhibition effects. [PDF]

Mol Genet Metab Rep
Munakata M, Iwamoto T, Chen W, Akiyama K, Eto Y.   +4 more
europepmc   +1 more source

Case Report: Is it COPD? It is Fabry disease: a case in which bronchodilators were briefly used but not continued, prioritizing enzyme replacement therapy. [PDF]

Front Pharmacol
Li Y, Zhu H, Zhan Z, Li G, Huang S, Xiao C, Li Y, Zheng C, Huang F.   +8 more
europepmc   +1 more source

Latent Epstein-Barr Virus Infection Correlates with Glycosphingolipid Enrichment and Morphological Remodeling of Extracellular Particles. [PDF]

Biology (Basel)
Zollo A, Centofanti L, Citro V, Corona A, Mingione A, Monzani C, Giannandrea D, Colombo EA, Serrao G, Gervasini C, Massa V, Neri A, Priori A, Miozzo MR, Signorelli P, Chiaramonte R, Dei Cas M, Martinelli-Boneschi F.   +17 more
europepmc   +1 more source

Immuno-Inflammatory Profiling and Complement Activation in Fabry Disease: A Cross-Sectional Study. [PDF]

Int J Mol Sci
Peña-Rodríguez M, Bara-Ledesma N, Fabregate M, Morales Conejo M, Domínguez-Rodríguez F, Merino-Ortiz B, Stanescu S, Ruiz-Sala P, González García A, Belanger-Quintana A, López-Rodríguez M.   +10 more
europepmc   +1 more source

Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease. [PDF]

Cells
Simonetta I, Baglio I, Tuttolomondo A.
europepmc   +1 more source

Effectiveness and tolerability of migalastat in adult Fabry disease: A single regional centre experience. [PDF]

Mol Genet Metab Rep
McCarron EP, Chinnadurai R, Stepien KM, Bassett J, Meyer J, Sharma R, Woolfson P, Jovanovic A.   +7 more
europepmc   +1 more source